CTBO (Cantabio Pharmaceuticals) Accounts Payable: $0.64 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Accounts Payable?

Cantabio Pharmaceuticals CTBO Accounts Payable is $0.64 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2018 was $0.64 Mil.

Cantabio Pharmaceuticals's quarterly Accounts Payable declined from Jun. 2018 ($0.66 Mil) to Sep. 2018 ($0.64 Mil) but then increased from Sep. 2018 ($0.64 Mil) to Dec. 2018 ($0.64 Mil).

Cantabio Pharmaceuticals's annual Accounts Payable increased from Mar. 2016 ($0.23 Mil) to Mar. 2017 ($0.38 Mil) and increased from Mar. 2017 ($0.38 Mil) to Mar. 2018 ($0.61 Mil).

Cantabio Pharmaceuticals Accounts Payable Related Terms

Cantabio Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Accounts Payable Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Accounts Payable
Get a 7-Day Free Trial 0.00 0.00 0.23 0.38 0.61

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.61 0.66 0.64 0.64

Cantabio Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.64 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Accounts Payable of $0.64 Mil as of Dec. 2018. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Accounts Payable too high?
Cantabio Pharmaceuticals' current Accounts Payable is $0.64 Mil.
How does Cantabio Pharmaceuticals' Accounts Payable compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Accounts Payable of $0.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Accounts Payable is $0.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Accounts Payable of $0.64 Mil. The current Accounts Payable is $0.64 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Accounts Payable is $0.64 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.